Crohn's disease is an idiopathic inflammatory disorder which can affect any segment of the digestive tract. Generally considered uncommon and often underestimated, it can endanger the patient's life due to its local and systemic complications. In this article we present the case of a 67-year-old male patient who was admitted for cramping abdominal pain, nonbloody diarrhea, fever and anorexia. He described a 5-year history of similar episodes composed of the same symptoms for which he was admitted. In the past no diagnosis was confirmed and he received no treatment, due to the fact that the episodes were autolimited and the patient didn't ask for medical attention. In this case surgery was required and the diagnosis of Crohn's disease was histopathologically confirmed, thus leading to a proper choice of treatment to avoid possible complications.
Hemangioma is the most common tumor of the vascular origin, benign, frequently observed in children, and with preference for head and neck, but rarely having a uvular origin. In this organ, it presents potential risk of local trauma, hemorrhage and it may produce great discomfort for the patient. In this article we present the cases of two patients (34 year-old and 44-year old) with uvular hemangiomas; patient 1 was admitted for dysphagia, salivation and choking and patient 2 was admitted for the swelling of the uvula, dysphagia, salivation and difficulty in speaking. They both presented a history of this symptoms, with acute episodes of dysphagia. They did not report bleeding, pain or fever. Hemangiomas were histopathologically confirmed, thus raising the awareness that hemangiomas are included in the differential diagnosis when a patient presents an elongated, swollen uvula or uvular masses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.